KOPECKA, Joanna
KOPECKA, Joanna
ONCOLOGIA
4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1H-pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/β-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells
2023-01-01 Masci, Domiziana; Puxeddu, Michela; Di Magno, Laura; D'Ambrosio, Michele; Parisi, Anastasia; Nalli, Marianna; Bai, Ruoli; Coluccia, Antonio; Sciò, Pietro; Orlando, Viviana; D'Angelo, Sara; Biagioni, Stefano; Urbani, Andrea; Hamel, Ernest; Nocentini, Alessio; Filiberti, Serena; Turati, Marta; Ronca, Roberto; Kopecka, Joanna; Riganti, Chiara; Fionda, Cinzia; Bordone, Rosa; Della Rocca, Giorgia; Canettieri, Gianluca; Supuran, Claudiu T; Silvestri, Romano; La Regina, Giuseppe
A LDL-masked liposomal-doxorubicin reverses drug resistance in human cancer cells
2011-01-01 Kopecka J; Campia I; Olivero P; Pescarmona GP; Ghigo D; Bosia A; Riganti C
ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma
2020-01-01 Belisario, Dimas Carolina; Akman, Muhlis; Godel, Martina; Campani, Virginia; Patrizio, Maria Pia; Scotti, Lorena; Hattinger, Claudia Maria; De Rosa, Giuseppe De; Donadelli, Massimo; Serra, Massimo; Kopecka, Joanna; Riganti, Chiara
An Autocrine Cytokine/JAK/STAT-Signaling Induces Kynurenine Synthesis in Multidrug Resistant Human Cancer Cells
2015-01-01 Campia, Ivana; Buondonno, Ilaria; Castella, Barbara; Rolando, Barbara; Kopecka, Joanna; Gazzano, Elena; Ghigo, Dario; Riganti, Chiara
Autocrine 17-β-estradiol/estrogen receptor-α loop determines the response to immune-checkpoint inhibitors in non-small cell lung cancer
2023-01-01 Anobile, Dario P; Salaroglio, Iris C; Tabbò, Fabrizio; La Vecchia, Sofia; Akman, Muhlis; Napoli, Francesca; Bungaro, Maristella; Benso, Federica; Aldieri, Elisabetta; Bironzo, Paolo; Kopecka, Joanna; Passiglia, Francesco; Righi, Luisella; Novello, Silvia; Scagliotti, Giorgio V; Riganti, Chiara
Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment
2018-01-01 Riganti, Chiara***; Lingua, MARCELLO FRANCESCO; Salaroglio, IRIS CHIARA; Falcomatà, Chiara; Righi, Luisella; Morena, Deborah; Francesca, Picca; Oddo, Daniele; Kopecka, Joanna; Pradotto, Monica; Libener, Roberta; Orecchia, Sara; Bironzo, Paolo; Comunanza, Valentina; Bussolino, Federico; Novello, Silvia; Scagliotti, Giorgio Vittorio; DI NICOLANTONIO, Federica***; Taulli, Riccardo***; ***corresponding authors
Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies
2020-01-01 Perez-Ruiz E.; Melero I.; Kopecka J.; Sarmento-Ribeiro A.B.; Garcia-Aranda M.; De Las Rivas J.
Carbonic Anhydrase XII Inhibitors Overcome P-Glycoprotein-Mediated Resistance to Temozolomide in Glioblastoma
2018-01-01 Salaroglio, Iris C; Mujumdar, Prashant; Annovazzi, Laura; Kopecka, Joanna; Mellai, Marta; Schiffer, Davide; Poulsen, Sally-Ann; Riganti, Chiara
Carbonic Anhydrase XII Inhibitors Overcome Temozolomide Resistance in Glioblastoma
2019-01-01 Mujumdar P.; Kopecka J.; Bua S.; Supuran C.T.; Riganti C.; Poulsen S.-A.
Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells
2015-01-01 J. Kopecka; I. Campia; A. Jacobs; AP. Frei; D. Ghigo; B. Wollscheid; C. Riganti
Cardiac glycosides as new modulators of cholesterol metabolism
2012-01-01 I. Campia; V. Sala; J. Kopecka; C. Leo; N. Mitro; C. Costamagna; D. Caruso; G. Pescarmona;T. Crepaldi; D. Ghigo; A. Bosia; C. Riganti
Cardiac glycosides modulate cholesterol metabolism via SREBP-2 and LXR activation
2013-01-01 I. Campia; V. Sala; J. Kopecka; C. Leo; N. Mitro; C. Costamagna; D. Caruso; G. Pescarmona;T. Crepaldi; D. Ghigo; A. Bosia; C. Riganti
Cardioactive glycosides induce the efflux of cholesterol by upregulating ABCA1
2012-01-01 I. Campia; J. Kopecka ;G. Pescarmona; D. Ghigo ; C. Riganti
Cholesterol metabolism: At the cross road between cancer cells and immune environment
2020-01-01 Kopecka J.; Godel M.; Riganti C.
Click ferrocenyl-erlotinib conjugates active against erlotinib-resistant non-small cell lung cancer cells in vitro
2021-01-01 Bieganski P.; Godel M.; Riganti C.; Kawano D.F.; Kopecka J.; Kowalski K.
Curcumin-loaded solid lipid nanoparticles bypass p-glycoprotein mediated doxorubicin resistance in triple negative breast cancer cells
2020-01-01 Abd-Ellatef G.-E.F.; Gazzano E.; Chirio D.; Hamed A.R.; Belisario D.C.; Zuddas C.; Peira E.; Rolando B.; Kopecka J.; Marie M.A.S.; Sapino S.; Fahmy S.R.; Gallarate M.; Abdel-Hamid A.-H.Z.; Riganti C.
Cytotoxic pathways activated by multifunctional thiosemicarbazones targeting sigma-2 receptors in breast and lung carcinoma cells
2023-01-01 Kopecka, Joanna; Barbanente, Alessandra; Vitone, Daniele; Arnesano, Fabio; Margiotta, Nicola; Berchialla, Paola; Niso, Mauro; Riganti, Chiara; Abate, Carmen
Design and synthesis of fluorescent ligands for the detection of cannabinoid type 2 receptor (CB2R)
2020-01-01 Spinelli F.; Giampietro R.; Stefanachi A.; Riganti C.; Kopecka J.; Abatematteo F.S.; Leonetti F.; Colabufo N.A.; Mangiatordi G.F.; Nicolotti O.; Perrone M.G.; Brea J.; Loza M.I.; Infantino V.; Abate C.; Contino M.
Digoxin and ouabain induce the efflux of cholesterol via LXR signalling and the synthesis of ATP in cardiomyocytes.
2012-01-01 Campia I; Sala V; Kopecka J; Leo C; Mitro N; Costamagna C; Caruso D; Pescarmona G; Crepaldi T; Ghigo D; Bosia A; Riganti C.
Digoxin and oubain increase the synthesis of cholesterol in human liver cells
2011-01-01 Joanna Kopecka; Ivana Campia; Amalia Bosia; Chiara Riganti
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1H-pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/β-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells | 2023 | Masci, Domiziana; Puxeddu, Michela; Di Magno, Laura; D'Ambrosio, Michele; Parisi, Anastasia; Nalli, Marianna; Bai, Ruoli; Coluccia, Antonio; Sciò, Pietro; Orlando, Viviana; D'Angelo, Sara; Biagioni, Stefano; Urbani, Andrea; Hamel, Ernest; Nocentini, Alessio; Filiberti, Serena; Turati, Marta; Ronca, Roberto; Kopecka, Joanna; Riganti, Chiara; Fionda, Cinzia; Bordone, Rosa; Della Rocca, Giorgia; Canettieri, Gianluca; Supuran, Claudiu T; Silvestri, Romano; La Regina, Giuseppe | |
| A LDL-masked liposomal-doxorubicin reverses drug resistance in human cancer cells | 2011 | Kopecka J; Campia I; Olivero P; Pescarmona GP; Ghigo D; Bosia A; Riganti C | |
| ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma | 2020 | Belisario, Dimas Carolina; Akman, Muhlis; Godel, Martina; Campani, Virginia; Patrizio, Maria Pia; Scotti, Lorena; Hattinger, Claudia Maria; De Rosa, Giuseppe De; Donadelli, Massimo; Serra, Massimo; Kopecka, Joanna; Riganti, Chiara | |
| An Autocrine Cytokine/JAK/STAT-Signaling Induces Kynurenine Synthesis in Multidrug Resistant Human Cancer Cells | 2015 | Campia, Ivana; Buondonno, Ilaria; Castella, Barbara; Rolando, Barbara; Kopecka, Joanna; Gazzano, Elena; Ghigo, Dario; Riganti, Chiara | |
| Autocrine 17-β-estradiol/estrogen receptor-α loop determines the response to immune-checkpoint inhibitors in non-small cell lung cancer | 2023 | Anobile, Dario P; Salaroglio, Iris C; Tabbò, Fabrizio; La Vecchia, Sofia; Akman, Muhlis; Napoli, Francesca; Bungaro, Maristella; Benso, Federica; Aldieri, Elisabetta; Bironzo, Paolo; Kopecka, Joanna; Passiglia, Francesco; Righi, Luisella; Novello, Silvia; Scagliotti, Giorgio V; Riganti, Chiara | |
| Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment | 2018 | Riganti, Chiara***; Lingua, MARCELLO FRANCESCO; Salaroglio, IRIS CHIARA; Falcomatà, Chiara; Righi, Luisella; Morena, Deborah; Francesca, Picca; Oddo, Daniele; Kopecka, Joanna; Pradotto, Monica; Libener, Roberta; Orecchia, Sara; Bironzo, Paolo; Comunanza, Valentina; Bussolino, Federico; Novello, Silvia; Scagliotti, Giorgio Vittorio; DI NICOLANTONIO, Federica***; Taulli, Riccardo***; ***corresponding authors | |
| Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies | 2020 | Perez-Ruiz E.; Melero I.; Kopecka J.; Sarmento-Ribeiro A.B.; Garcia-Aranda M.; De Las Rivas J. | |
| Carbonic Anhydrase XII Inhibitors Overcome P-Glycoprotein-Mediated Resistance to Temozolomide in Glioblastoma | 2018 | Salaroglio, Iris C; Mujumdar, Prashant; Annovazzi, Laura; Kopecka, Joanna; Mellai, Marta; Schiffer, Davide; Poulsen, Sally-Ann; Riganti, Chiara | |
| Carbonic Anhydrase XII Inhibitors Overcome Temozolomide Resistance in Glioblastoma | 2019 | Mujumdar P.; Kopecka J.; Bua S.; Supuran C.T.; Riganti C.; Poulsen S.-A. | |
| Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells | 2015 | J. Kopecka; I. Campia; A. Jacobs; AP. Frei; D. Ghigo; B. Wollscheid; C. Riganti | |
| Cardiac glycosides as new modulators of cholesterol metabolism | 2012 | I. Campia; V. Sala; J. Kopecka; C. Leo; N. Mitro; C. Costamagna; D. Caruso; G. Pescarmona;T. Crepaldi; D. Ghigo; A. Bosia; C. Riganti | |
| Cardiac glycosides modulate cholesterol metabolism via SREBP-2 and LXR activation | 2013 | I. Campia; V. Sala; J. Kopecka; C. Leo; N. Mitro; C. Costamagna; D. Caruso; G. Pescarmona;T. Crepaldi; D. Ghigo; A. Bosia; C. Riganti | |
| Cardioactive glycosides induce the efflux of cholesterol by upregulating ABCA1 | 2012 | I. Campia; J. Kopecka ;G. Pescarmona; D. Ghigo ; C. Riganti | |
| Cholesterol metabolism: At the cross road between cancer cells and immune environment | 2020 | Kopecka J.; Godel M.; Riganti C. | |
| Click ferrocenyl-erlotinib conjugates active against erlotinib-resistant non-small cell lung cancer cells in vitro | 2021 | Bieganski P.; Godel M.; Riganti C.; Kawano D.F.; Kopecka J.; Kowalski K. | |
| Curcumin-loaded solid lipid nanoparticles bypass p-glycoprotein mediated doxorubicin resistance in triple negative breast cancer cells | 2020 | Abd-Ellatef G.-E.F.; Gazzano E.; Chirio D.; Hamed A.R.; Belisario D.C.; Zuddas C.; Peira E.; Rolando B.; Kopecka J.; Marie M.A.S.; Sapino S.; Fahmy S.R.; Gallarate M.; Abdel-Hamid A.-H.Z.; Riganti C. | |
| Cytotoxic pathways activated by multifunctional thiosemicarbazones targeting sigma-2 receptors in breast and lung carcinoma cells | 2023 | Kopecka, Joanna; Barbanente, Alessandra; Vitone, Daniele; Arnesano, Fabio; Margiotta, Nicola; Berchialla, Paola; Niso, Mauro; Riganti, Chiara; Abate, Carmen | |
| Design and synthesis of fluorescent ligands for the detection of cannabinoid type 2 receptor (CB2R) | 2020 | Spinelli F.; Giampietro R.; Stefanachi A.; Riganti C.; Kopecka J.; Abatematteo F.S.; Leonetti F.; Colabufo N.A.; Mangiatordi G.F.; Nicolotti O.; Perrone M.G.; Brea J.; Loza M.I.; Infantino V.; Abate C.; Contino M. | |
| Digoxin and ouabain induce the efflux of cholesterol via LXR signalling and the synthesis of ATP in cardiomyocytes. | 2012 | Campia I; Sala V; Kopecka J; Leo C; Mitro N; Costamagna C; Caruso D; Pescarmona G; Crepaldi T; Ghigo D; Bosia A; Riganti C. | |
| Digoxin and oubain increase the synthesis of cholesterol in human liver cells | 2011 | Joanna Kopecka; Ivana Campia; Amalia Bosia; Chiara Riganti |